• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

FDA-TRACK

The list below provides information on FDA’s performance measures and projects as aligned to FDA strategic priorities and program offices. This list enables you to view charts of performance data and progress on important projects and programs.

To view completed FDA-TRACK performance measures and projects view the Archive Index

Filter








Results

Number of results: 43

ItemProgramOfficeStrategic PlanStrategic Goal/Area
1Total number of training events in the monthCDRHAllCDRH Strategic PlanStrengthen Our Workforce and Workplace
2Total number of CDRH employees who completed training events in the monthCDRHAllCDRH Strategic PlanStrengthen Our Workforce and Workplace
3Percent of CDRH intra- and inter-Office eConsults completed on time during the monthCDRHAllCDRH Strategic PlanCross-Cutting Measure
4Total number of OCD employees who completed training events in the monthCDRHOffice of the Center DirectorCDRH Strategic PlanStrengthen Our Workforce and Workplace
5Cumulative percent of guidance documents cleared by OCDCDRHOffice of the Center DirectorCDRH Strategic PlanCross-Cutting Measure
6Cumulative number of CDRH 2013 Strategic Priorities actions listed in the plan completedCDRHOffice of the Center DirectorCDRH Strategic PlanCross-Cutting Measure
7Total number of OMO employees who completed training events in the monthCDRHOffice of Management OperationsCDRH Strategic PlanStrengthen Our Workforce and Workplace
8Percent of CTRS-reporting employees who reported their time during the quarterCDRHOffice of Management OperationsCDRH Strategic PlanCross-Cutting Measure
9Develop and Implement Revised CDRH Honor Awards ProcessCDRHOffice of Management OperationsCDRH Strategic PlanStrengthen Our Workforce and Workplace
10Total number of OCER employees who completed training events in the monthCDRHOffice of Communication, Education and Radiation ProgramsCDRH Strategic PlanStrengthen Our Workforce and Workplace
11Percent of OCER intra- and inter-Office eConsults completed on time during the monthCDRHOffice of Communication, Education and Radiation ProgramsCDRH Strategic PlanCross-Cutting Measure
12Percent of CDRH web documents posted within established time framesCDRHOffice of Communication, Education and Radiation ProgramsCDRH Strategic PlanEnhance Communication and Transparency
13Number of CDRH web pages updated during the monthCDRHOffice of Communication, Education and Radiation ProgramsCDRH Strategic PlanEnhance Communication and Transparency
14Develop a CDRH Employee Resource CenterCDRHOffice of Communication, Education and Radiation ProgramsCDRH Strategic PlanStrengthen Our Workforce and Workplace
15Total number of OC employees who completed training events in the monthCDRHOffice of ComplianceCDRH Strategic PlanStrengthen Our Workforce and Workplace
16Percent of OC intra- and inter-Office eConsults completed on time during the monthCDRHOffice of ComplianceCDRH Strategic PlanCross-Cutting Measure
17Percent of recalls (I, II, and III) meeting OC timeframes classified during the monthCDRHOffice of ComplianceCDRH Strategic PlanPatients in the U.S. have Access to High-Quality, Safe, and Effective Medical Devices of Public Health Importance First in the World
18Medical Device Single Audit Program (MDSAP)CDRHOffice of ComplianceCDRH Strategic PlanDevices are Legally Marketed in the U.S. and Remain Safe, Effective, and of High-Quality
19Total number of OSEL employees who completed training events in the monthCDRHOffice of Science and Engineering LaboratoriesCDRH Strategic PlanStrengthen Our Workforce and Workplace
20Percent of OSEL intra- and inter-Office eConsults completed on time during the monthCDRHOffice of Science and Engineering LaboratoriesCDRH Strategic PlanCross-Cutting Measure
21Number of OSEL-generated research papers about medical device related issues published during the monthCDRHOffice of Science and Engineering LaboratoriesCDRH Strategic PlanPatients in the U.S. have Access to High-Quality, Safe, and Effective Medical Devices of Public Health Importance First in the World
22Number of scientific and technical training classes and presentations (internal and external) by OSEL staff during the monthCDRHOffice of Science and Engineering LaboratoriesCDRH Strategic PlanPatients in the U.S. have Access to High-Quality, Safe, and Effective Medical Devices of Public Health Importance First in the World
23Number of technical reviews of new applications and data supporting requests for premarket approvals completedCDRHOffice of Science and Engineering LaboratoriesCDRH Strategic PlanPatients in the U.S. have Access to High-Quality, Safe, and Effective Medical Devices of Public Health Importance First in the World
24Number of technical analyses of postmarket device problems and performance completedCDRHOffice of Science and Engineering LaboratoriesCDRH Strategic PlanPatients in the U.S. have Access to High-Quality, Safe, and Effective Medical Devices of Public Health Importance First in the World
25Improving the Use of Computational Fluid Dynamic (CFD) Techniques to Evaluate Performance and Blood Damage Safety in Medical DevicesCDRHOffice of Science and Engineering LaboratoriesCDRH Strategic PlanPatients in the U.S. have Access to High-Quality, Safe, and Effective Medical Devices of Public Health Importance First in the World
26Total number of OSB employees who completed training events in the monthCDRHOffice of Surveillance and BiometricsCDRH Strategic PlanStrengthen Our Workforce and Workplace
27Percent of OSB intra- and inter-Office eConsults completed on time during the monthCDRHOffice of Surveillance and BiometricsCDRH Stratgic PlanCross-Cutting Measure
28Percent of PAS decision letters completed within established time frames during the monthCDRHOffice of Surveillance and BiometricsCDRH Strategic PlanFully Implement a Total Product Life Cycle Approach
29Percent of death MDRs reviewed within 5 business days during the monthCDRHOffice of Surveillance and BiometricsCDRH Strategic PlanFully Implement a Total Product Life Cycle Approach
30Percent of “Code Blue” MDRs reviewed within 72 hours during the monthCDRHOffice of Surveillance and BiometricsCDRH Strategic PlanFully Implement a Total Product Life Cycle Approach
31Unique Device Identification Database (UDID)CDRHOffice of Surveillance and BiometricsCDRH Strategic PlanFully Implement a Total Product Life Cycle Approach
32Total number of ODE employees who completed training events in the monthCDRHOffice of Device EvaluationCDRH Strategic PlanStrengthen Our Workforce and Workplace
33Percent of ODE intra- and inter-Office eConsults completed on time during the monthCDRHOffice of Device EvaluationCDRH Strategic PlanCross-Cutting Measure
34Total number of OIR employees who completed training events in the monthCDRHOffice of In Vitro Diagnostics and Radiological HealthCDRH Strategic PlanStrengthen Our Workforce and Workplace
35Percent of OIR intra- and inter-Office eConsults completed on time during the monthCDRHOffice of In Vitro Diagnostics and Radiological HealthCDRH Strategic PlanCross-Cutting Measure
36Percent of CDRH (ODE and OIR) 510(k) decisions meeting MDUFA goals during the monthCDRHPremarket OfficesCDRH Strategic PlanPatients in the U.S. have Access to High-Quality, Safe, and Effective Medical Devices of Public Health Importance First in the World
37Percent of ODE 510(k) decisions meeting MDUFA goals during the monthCDRHOffice of Device EvaluationCDRH Strategic PlanPatients in the U.S. have Access to High-Quality, Safe, and Effective Medical Devices of Public Health Importance First in the World
38Percent of OIR 510(k) decisions meeting MDUFA goals during the monthCDRHOffice of In Vitro Diagnostics and Radiological HealthCDRH Strategic PlanPatients in the U.S. have Access to High-Quality, Safe, and Effective Medical Devices of Public Health Importance First in the World
39Percent of CDRH (ODE and OIR) 180-Day PMA Supplements decisions made in 180 days or less during the quarterCDRHPremarket OfficesCDRH Strategic PlanPatients in the U.S. have Access to High-Quality, Safe, and Effective Medical Devices of Public Health Importance First in the World
40Percent of ODE 180-Day PMA Supplements decisions made in 180 days or less during the quarterCDRHOffice of Device EvaluationCDRH Strategic PlanPatients in the U.S. have Access to High-Quality, Safe, and Effective Medical Devices of Public Health Importance First in the World
41Percent of OIR 180-Day PMA Supplements decisions made in 180 days or less during the quarterCDRHOffice of In Vitro Diagnostics and Radiological HealthCDRH Strategic PlanPatients in the U.S. have Access to High-Quality, Safe, and Effective Medical Devices of Public Health Importance First in the World
42Percent of eRadHealth submissions submitted electronically during the monthCDRHOffice of In Vitro Diagnostics and Radiological HealthCDRH Strategic PlanThe U.S. is the World’s Leader in Regulatory Science, Medical Device Innovation and Manufacturing, and Radiation-Emitting Product Safety
43Personalized MedicineCDRHOffice of In Vitro Diagnostics and Radiological HealthCDRH Strategic PlanPatients in the U.S. have Access to High-Quality, Safe, and Effective Medical Devices of Public Health Importance First in the World

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information in the Archive Index may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.